Table 1.
Model | Demographic | Lifestyle | Personal and family history | Blood-based biomarkers | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age | Sex | Alcohol | BMI | Diet | PA | Smoking | WHR | Cirrhosis | Diabetes | Hepatitis | ALT | AST | GGT | TG | |
BARD | • | • | • | • | |||||||||||
Cao-2021a | • | • | • | • | •b | ||||||||||
CAP-Bc | • | • | • | • | • | •d | • | • | |||||||
CLivD (lab) | • | • | • | • | • | • | • | ||||||||
CLivD (non-lab) | • | • | • | • | • | • | |||||||||
dAAR | • | • | • | ||||||||||||
DM-HCC | • | • | • | ||||||||||||
HLI | • | • | • | • | • | • | • | ||||||||
Li-2018e | • | • | • | • | • | • | |||||||||
Sinn-2020 | • | • | • | • | • | • | |||||||||
Wen 1-2012 | • | • | • | • | • | • | |||||||||
Wen 2-2012 | • | • | • | • | |||||||||||
Wen 3-2012 | • | • | • | • | • | • | • | • |
Abbreviations: ALT Alanine aminotransferase, AST Aspartate aminotransferase, BMI Body mass index, GGT Gamma-glutamyl transferase, HBV Hepatitis B virus, HCV Hepatitis C virus, PA Physical activity, TG Triglycerides, WHR Waist-to-hip ratio
aPsychological trauma was included as an additional predictor in Cao-2021
bCirrhosis was defined as medical history of liver diseases in mothers
cAdditional predictors included income, statin exposure, and antiplatelet
dHepatitis was defined as hepatitis C
eAdditional predictors included HbA1c, antidiabetes medication, antihyperlipidemia medication, and THR, which was included as an additional predictor in Li-2018